Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
February 25 2025 - 4:05PM
Edgar (US Regulatory)
Exhibit
1
JOINT
FILING AGREEMENT
The
undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and that
all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity
of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of
such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible
for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe
that such information is inaccurate.
Dated: February 25, 2025 |
|
|
|
Commodore Capital LP |
|
|
|
|
By: |
/s/ Michael
Kramarz |
|
Michael Kramarz, Managing Partner |
|
|
|
|
Commodore Capital Master LP |
|
|
|
|
By: |
/s/ Michael
Kramarz |
|
Michael Kramarz, Authorized Signatory |
|
Solid Biosciences (NASDAQ:SLDB)
Historical Stock Chart
From Feb 2025 to Mar 2025
Solid Biosciences (NASDAQ:SLDB)
Historical Stock Chart
From Mar 2024 to Mar 2025